Changjin Biotechnology
Shanghai
About Changjin Biotechnology
Changjin Biotechnology specializes in the research and development of edible microbial synthetic proteins for the food sector.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Total funding: $30.6M
- Funding stage: Early Stage Venture
- Last round: Series B (Aug 2025)
- Website: chgbio.com
Industries & Categories
AgTech, Biotechnology, Genetics, Life Science
Social Profiles
Canonical: https://fsome.com/organization/changjin-biotechnology-66386 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.